ACC.26 advanced registration ends Feb. 12 – register now!

Alexandra Charrow, MD

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Avalo(MODEST), UCB Inc.(MODEST), Incyte Corporation(MODEST) RESEARCH/RESEARCH GRANTS: Sonoma(NONE), Incyte Corporation(NONE)

View Full Disclosure